Story perspectives

Sen. Cassidy Unveils FDA Overhaul for Faster Approvals

2/18/2026

Summary

Story summary

Sen. Bill Cassidy (R-La.) presented February 17, 2026, a report to modernize the Food and Drug Administration (FDA).
The report outlines more than a dozen recommendations to cut bottlenecks and speed approvals.
Cassidy criticized inconsistent FDA review practices and urged innovative clinical trials.
The document notes lack of GRAS ingredient oversight, with minimal re-evaluations since 2010.
The report aims to improve patient access and U.S. medical research competitiveness.

1 of 1

Story summary

Sen. Bill Cassidy (R-La.) presented February 17, 2026, a report to modernize the Food and Drug Administration (FDA).
The report outlines more than a dozen recommendations to cut bottlenecks and speed approvals.
Cassidy criticized inconsistent FDA review practices and urged innovative clinical trials.
The document notes lack of GRAS ingredient oversight, with minimal re-evaluations since 2010.
The report aims to improve patient access and U.S. medical research competitiveness.